Search

everythinglearnresearchcommunity

for

Search:↓

Intramuscular triamcinolone and pulse therapy with oral predonine are effective for alopecia areata with manageable side effects, but better relapse prevention is needed.

A woman's hair grew back while she was taking sulphasalazine for arthritis.

Both azathioprine and betamethasone treatments help with hair regrowth in alopecia areata, but azathioprine may have fewer side effects.

Intralesional vitamin D3 is an effective and safe treatment for patchy alopecia areata with fewer side effects.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Baricitinib was more effective than a placebo in regrowing hair in adults with alopecia areata after 36 weeks.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

New medications could improve treatment for severe alopecia areata in Australia.

Ixekizumab is safe for long-term use with low rates of major heart-related events.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

The drug Olumiant is now approved to treat severe hair loss from alopecia and can also be used for some hospitalized COVID-19 patients.

Baricitinib is the most effective treatment for alopecia areata.

Anifrolumab improves quality of life and reduces steroid use in SLE patients.

Intensive immunosuppression can reduce relapse rates in multiple sclerosis patients, despite some side effects.

JAK inhibitors are effective for long-term management of alopecia areata.

Dupilumab can help regrow hair and improve skin conditions in patients with severe atopic dermatitis and alopecia areata.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

A medication for skin rash also unexpectedly treated hair loss in a patient.

Most skin rashes in rheumatoid arthritis patients were not caused by their medication, and careful evaluation allowed most to keep taking their beneficial treatment.

JAK inhibition may help manage autoimmune conditions in Down syndrome.

Systemic corticosteroids might help treat hair loss caused by alemtuzumab in MS patients.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Tralokinumab successfully treated alopecia areata in a patient with atopic dermatitis.

Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.

Risankizumab effectively treats and maintains skin clearance in moderate-to-severe psoriasis.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Both treatments improved alopecia areata, but methotrexate caused more skin darkening, while triamcinolone caused skin lightening and thinning.